Cervical Cancer HPV Vaccine

Gratis

0
0
1
2 years ago
Preview
Full text

  Title: Cervical Cancer HPV Vaccine Word Count: 517 Summary: Gardasil is a recently released vaccine aimed at protecting women against cervical cancer and the human papilloma virus (HPV) that causes it.

  Keywords: gardisal, hpv, vaccine, cervical cancer, skin, dermatology Article Body: <b>Gardasil:</b> Cervical cancer is caused by a virus many people get in their teens and 20s. Now there is a vaccine available to protect women from the most common cause of cervical cancer: a virus called HPV. <b>What is HPV?</b> HPV (human papillomavirus) is a common virus that affects both females and males. There are actually more than 100 types of HPV. Most of them are relatively harmless, like the ones that cause common warts on the hands and feet. For most people, the body´s own defense system will clear the virus. However, there are a few types of HPV you should really know about. <b>Genital HPV:</b> About 30 types of HPV affect the genital area.

  • Some are ˆhigh-risk˜ types (such as HPV Types 16 and 18) that can cause abnormal cervical cells and cervical cancer - Others are ˆlow-risk˜ types (such as HPV Types 6 and 11) that can cause genital warts. <b>Genital Warts:</b> Genital warts are usually flesh-colored growths that are most often caused by certain ˆlow-risk˜ types of HPV. Anyone who has any kind of sexual activity involving genital contact can get HPV and genital warts ˘ intercourse isn´t necessary. And many people with HPV do not have genital warts or any other symptoms, so they can pass the virus without even knowing it. The warts may appear within weeks, months ˘ or sometimes not at all. <b>More common than you might think:</b> The Center for Disease Control (CDC) estimates that 80% of women will have had genital HPV by age 50. It´s estimated that most people get HPV within their first 2 to 3 years of becoming sexually active. <b>A cancer vaccine?</b> Gardasil is a vaccine that helps protect against the following diseases (these are diseases caused by the HPV Types in the vaccine (6, 11, 16, and 18)):
  • Cervical cancer
  • Abnormal and precancerous cervical lesions
  • Abnormal and precancerous vaginal lesions
  • Genital warts Gardasil is indicated for girls and women ages 9 through 26. The vaccine is given as a series of three injections at 0, 2, and 6 months. Gardasil is intended to prevent, not treat, the above mentioned diseases. However, you may benefit from Gardasil if you already have HPV. This is because most people are not infected with all four types of HPV contained in the vaccine. In clinical trials, individuals with one or more vaccine-related HPV types prior to vaccination were protected from disease caused by the remaining vaccine HPV types. <b>What about women of other ages and men?</b> The main purpose Gardasil is to protect women against the HPV types that cause cervical cancer. Men are obviously not at risk for cervical cancer so, at this time, there are no efforts to vaccinate men. Some men may choose, however, to get the vaccine simply for the partial protection it will give them against contracting genital warts. How effective the vaccine is at protecting men from genital warts has not yet been sufficiently studied. The age range for women is based on the fact that HPV is a sexually transmitted virus that most women encounter within the first 2 to 3 years of being sexually active. This is a demo version of txt2pdf v.10.1 Developed by SANFACE Software http://www.sanface.com/

Dokumen baru

Dokumen yang terkait

Kemampuan Sitologi Biopsi Jarum Halus pada Cervical Adenopati yang Diduga Metastasis Karsinoma Nasofaring dalam Menentukan Kejadian Karsinoma Nasofaring pada Periode Januari – Desember 2012
0
40
67
Perawatan Pasien Dengan Kolostomi Pada Penderita Cancer Colorectal
0
23
10
Derajat Parasitemia Mencit BALB/c Pasca Vaksinasi Kelenjar saliva Anopheles aconitus sebagai Model Transmission Blocking Vaccine (TBV) terhadap Malaria
0
9
13
DERAJAT PARASITEMIA MENCIT GALUR BALB/c YANG DIVAKSINASI KELENJAR SALIVA Anopheles sundaicus SEBAGAI MODEL Transmission Blocking Vaccine (TBV) MELAWAN MALARIA
0
4
15
DERAJAT PARASITEMIA MENCIT GALUR BALB/c YANG DIVAKSINASI KELENJAR SALIVA Anopheles sundaicus SEBAGAI MODEL Transmission Blocking Vaccine (TBV) MELAWAN MALARIA
0
4
15
Derajat Parasitemia Mencit Galur BALB/c yang Divaksinasi Kelenjar Saliva Anopheles sundaicus sebagai Model Transmission Blocking Vaccine (TBV) Melawan Malaria
0
4
5
Hubungan antara Dukungan Sosial dan Resiliensi dengan Kualitas Hidup Pasien Kanker Serviks di RSD. Dr. Soebandi Jember (Relationship between Social Support and Resilience with Quality of Life of Cervical Cancer Patients in Dr. Soebandi Jember Hospital)
0
17
9
The Influence of Hormonal Contraceptive Use to Breast Cancer in dr. Soebandi Jember Hospital
0
5
20
Karakterisasi molekul saliva nyamuk Anopheles srmdaicus strain local sebagai target potensial dalam pembuatan Transmission Blocking Vaccine (TBV) melawan malaria
0
3
4
Karakterisasi molekul saliva nyamuk Anopheles sundaicus strain local sebagai target potensial dalam pembuatan Transmission Blocking Vaccine (TBV) melawan malaria
0
18
4
Karakterisasi Protein Saliva Nyamuk Anopheles sundaicus sebagai Target Potensial dalam Pembuatan Transmission Blocking Vaccine (TBV) Melawan Malaria
0
24
15
Strategi Komunikasi Corporate Communication PT. BIO Farma (Persero) Melalui Program School Of Vaccine For Journalisat Dalam memotivasi Jurnalis Menulis Artikel Vaksin
1
8
45
CANCER IMMUNOLOGY Eryati Darwin, Faculty of Medicine Andalas University- Padang I. INTRODUCTION - Cancer Immunology | Darwin | Jurnal Kesehatan Andalas
0
0
14
In Vitro Cytotoxic Study and Detection of Apoptosis on Breast Cancer Cell lines MDA-MB 231 after Exposed to Azadirachta Indica A. Juss (neem) Extract
0
0
5
Spondilitis Tuberkulosa Cervical | Saputra | Jurnal Kesehatan Andalas
0
2
10
Show more